Determinants of Steady-State Torasemide Pharmacokinetics: Impact of Pharmacogenetic Factors, Gender and Angiotensin II Receptor Blockers

Author： Werner Dierk  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.47, Iss.5, 2008-01, pp. : 323-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular and metabolic effects of angiotensin II receptor blockers

By Barra Silvia   Vitagliano Alice   Cuomo Vittoria   Vitagliano Giancarlo   Gaeta Giovanni  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 173-189

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II receptor blockers in the prevention of atrial fibrillation

By Barra Silvia   Silvestri Nunzia   Vitagliano Giancarlo   Madrid Alfredo   Gaeta Giovanni  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1395-1411

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II receptor blockers for the treatment of hypertension

By See Sharon  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 11, 2001-11 ,pp. : 1795-1804

Informa Healthcare

Access to resources Recommend Favorite

Gender Differences in the Effects of Angiotensin Receptor Blockers on Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 11, 2011-04 ,pp. : 1090-1094

Bentham Science Publishers

Access to resources Recommend Favorite

Role of angiotensin II receptor blockers in atherosclerotic plaque stability

By Cipollone Francesco   Fazia Maria Luigia   Mezzetti Andrea  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 3, 2006-02 ,pp. : 277-285

Informa Healthcare

Access to resources Recommend Favorite